The cancer genome atlas pan-cancer analysis project JN Weinstein, EA Collisson, GB Mills, KR Shaw, BA Ozenberger, K Ellrott, ... Nature genetics 45 (10), 1113-1120, 2013 | 7107 | 2013 |
Comprehensive molecular characterization of gastric adenocarcinoma Cancer Genome Atlas Research Network Nature 513 (7517), 202, 2014 | 5440 | 2014 |
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia Cancer Genome Atlas Research Network New England Journal of Medicine 368 (22), 2059-2074, 2013 | 4896 | 2013 |
Comprehensive molecular characterization of clear cell renal cell carcinoma Cancer Genome Atlas Research Network Analysis working group: Baylor College ... Nature 499 (7456), 43-49, 2013 | 2942 | 2013 |
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin KA Hoadley, C Yau, DM Wolf, AD Cherniack, D Tamborero, S Ng, ... Cell 158 (4), 929-944, 2014 | 1583 | 2014 |
Integrated genomic characterization of oesophageal carcinoma Cancer Genome Atlas Research Network Nature 541 (7636), 169, 2017 | 1378 | 2017 |
Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes MDM Leiserson, F Vandin, HT Wu, JR Dobson, JV Eldridge, JL Thomas, ... Nature genetics 47 (2), 106-114, 2015 | 969 | 2015 |
Analysis of plasma cell-free DNA by ultradeep sequencing in patients with stages I to III colorectal cancer T Reinert, TV Henriksen, E Christensen, S Sharma, R Salari, H Sethi, ... JAMA oncology 5 (8), 1124-1131, 2019 | 745 | 2019 |
Comprehensive pan-genomic characterization of adrenocortical carcinoma S Zheng, AD Cherniack, N Dewal, RA Moffitt, L Danilova, BA Murray, ... Cancer cell 29 (5), 723-736, 2016 | 682 | 2016 |
Early detection of metastatic relapse and monitoring of therapeutic efficacy by ultra-deep sequencing of plasma cell-free DNA in patients with urothelial bladder carcinoma E Christensen, K Birkenkamp-Demtröder, H Sethi, S Shchegrova, R Salari, ... Journal of Clinical Oncology 37 (18), 1547-1557, 2019 | 455 | 2019 |
Personalized detection of circulating tumor DNA antedates breast cancer metastatic recurrence RC Coombes, K Page, R Salari, RK Hastings, A Armstrong, S Ahmed, ... Clinical Cancer Research 25 (14), 4255-4263, 2019 | 418 | 2019 |
The integrated genomic landscape of thymic epithelial tumors M Radovich, CR Pickering, I Felau, G Ha, H Zhang, H Jo, KA Hoadley, ... Cancer cell 33 (2), 244-258. e10, 2018 | 330 | 2018 |
Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival MJM Magbanua, LB Swigart, HT Wu, GL Hirst, C Yau, DM Wolf, A Tin, ... Annals of Oncology 32 (2), 229-239, 2021 | 329 | 2021 |
CoMEt: a statistical approach to identify combinations of mutually exclusive alterations in cancer MDM Leiserson, HT Wu, F Vandin, BJ Raphael Genome biology 16, 1-20, 2015 | 245 | 2015 |
An integrative probabilistic model for identification of structural variation in sequencing data SS Sindi, S Önal, LC Peng, HT Wu, BJ Raphael Genome biology 13, 1-25, 2012 | 178 | 2012 |
Identification of ovarian cancer metastatic miRNAs S Vang, HT Wu, A Fischer, DH Miller, S MacLaughlan, E Douglass, ... PloS one 8 (3), e58226, 2013 | 105 | 2013 |
Identifying structural variants using linked-read sequencing data R Elyanow, HT Wu, BJ Raphael Bioinformatics 34 (2), 353-360, 2018 | 84 | 2018 |
A phase II study of talazoparib monotherapy in patients with wild-type BRCA1 and BRCA2 with a mutation in other homologous recombination genes JJ Gruber, A Afghahi, K Timms, A DeWees, W Gross, VN Aushev, HT Wu, ... Nature Cancer 3 (10), 1181-1191, 2022 | 77 | 2022 |
Expression profiling of primary and metastatic ovarian tumors reveals differences indicative of aggressive disease AS Brodsky, A Fischer, DH Miller, S Vang, S MacLaughlan, HT Wu, J Yu, ... PloS one 9 (4), e94476, 2014 | 72 | 2014 |
Personalized serial circulating tumor DNA (ctDNA) analysis in high-risk early stage breast cancer patients to monitor and predict response to neoadjuvant therapy and outcome in … M Magbanua, L Brown-Swigart, G Hirst, C Yau, D Wolf, AA Ma, E Bergin, ... Data presented at spotlight session: San Antonio Breast Cancer Symposium, 2018 | 65 | 2018 |